Third-trimester erythrocytapheresis in pregnant patients with sickle cell disease
Abstract Objective To evaluate the effects of prophylactic transfusion by means of erythrocytapheresis at the beginning of the third trimester of pregnancy in women with sickle cell disease (SCD). Methods A cohort of 14 pregnant women with SCD who received prophylactic erythrocytapheresis transfusio...
Gespeichert in:
| Veröffentlicht in: | International journal of gynecology and obstetrics 2007-01, Vol.96 (1), p.8-11 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 11 |
|---|---|
| container_issue | 1 |
| container_start_page | 8 |
| container_title | International journal of gynecology and obstetrics |
| container_volume | 96 |
| creator | Gilli, S.C De Paula, E.V Biscaro, F.P Marques, J.F Costa, F.F Saad, S.T |
| description | Abstract Objective To evaluate the effects of prophylactic transfusion by means of erythrocytapheresis at the beginning of the third trimester of pregnancy in women with sickle cell disease (SCD). Methods A cohort of 14 pregnant women with SCD who received prophylactic erythrocytapheresis transfusions at the beginning of the third trimester was retrospectively compared with a cohort of 17 pregnant women who received simple prophylactic transfusions for no indication other than SCD severity. Results Prophylactic erythrocytapheresis transfusions were associated with a lower risk of intrauterine growth restriction (OR, 0.11; 95% confidence interval, 0.01–1.00) and oligohydramnios (OR, 0.65; 95% confidence interval, 0.45–0.92) in pregnant women with SCD. Conclusion These results suggest that erythrocytapheresis transfusions are beneficial in women with SCD who are in the third trimester of pregnancy. Given the decrease in transfusion risks, this therapy deserves further evaluation in future trials. |
| doi_str_mv | 10.1016/j.ijgo.2006.09.017 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68935060</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0020729206004541</els_id><sourcerecordid>68935060</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4858-af8f9ff308e751dd0f6ec0342400581cb7113a80fcd36eb296876302d039a4663</originalsourceid><addsrcrecordid>eNqNkkGL1DAUx4Mo7rj6BTxIL3prfUnaNAURZNF1ZWER13PIJK876Xbamtdx6bc3ZQYWPIinXH7_l39-eYy95lBw4Op9V4TubiwEgCqgKYDXT9iG67rJZVk3T9kGQEBei0acsRdEHUBCOH_OztKhtaj5hn2_3YXo8zmGPdKMMcO4zLs4umW20w4jUqAsDNkU8W6ww5xNdg44zJQ9hHmXUXD3PWYO-z7zgdASvmTPWtsTvjqd5-znl8-3F1_z65vLq4tP17krdaVz2-q2aVsJGuuKew-tQgeyFCVApbnbpqbSamidlwq3olG6VhKEB9nYUil5zt4d505x_HVI5c0-0FrEDjgeyCjdyAoUJFAcQRdHooitmdJrbVwMB7OKNJ1ZRZpVpIHGJEsp9OY0_bDdo3-MnMwl4O0JsORs30Y7uECPnE4dtdaJq47cQ-hx-Y-rzdW3y5s19-GYw-Twd8BoyCXxDn2I6Gbjx_Dv_h__irs-DCE1vccFqRsPcUi_Y7ghYcD8WFdl3ZQkDMqq5PIPrLS3ZQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68935060</pqid></control><display><type>article</type><title>Third-trimester erythrocytapheresis in pregnant patients with sickle cell disease</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Gilli, S.C ; De Paula, E.V ; Biscaro, F.P ; Marques, J.F ; Costa, F.F ; Saad, S.T</creator><creatorcontrib>Gilli, S.C ; De Paula, E.V ; Biscaro, F.P ; Marques, J.F ; Costa, F.F ; Saad, S.T</creatorcontrib><description>Abstract Objective To evaluate the effects of prophylactic transfusion by means of erythrocytapheresis at the beginning of the third trimester of pregnancy in women with sickle cell disease (SCD). Methods A cohort of 14 pregnant women with SCD who received prophylactic erythrocytapheresis transfusions at the beginning of the third trimester was retrospectively compared with a cohort of 17 pregnant women who received simple prophylactic transfusions for no indication other than SCD severity. Results Prophylactic erythrocytapheresis transfusions were associated with a lower risk of intrauterine growth restriction (OR, 0.11; 95% confidence interval, 0.01–1.00) and oligohydramnios (OR, 0.65; 95% confidence interval, 0.45–0.92) in pregnant women with SCD. Conclusion These results suggest that erythrocytapheresis transfusions are beneficial in women with SCD who are in the third trimester of pregnancy. Given the decrease in transfusion risks, this therapy deserves further evaluation in future trials.</description><identifier>ISSN: 0020-7292</identifier><identifier>EISSN: 1879-3479</identifier><identifier>DOI: 10.1016/j.ijgo.2006.09.017</identifier><identifier>PMID: 17188271</identifier><identifier>CODEN: IJGOAL</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>Adult ; Anemia, Sickle Cell - therapy ; Anemias. Hemoglobinopathies ; Biological and medical sciences ; Blood Component Removal ; Diseases of red blood cells ; Erythrocytapheresis ; Erythrocyte Transfusion ; Female ; Fetal Growth Retardation - prevention & control ; Gynecology. Andrology. Obstetrics ; Hematologic and hematopoietic diseases ; Hemoglobin SC Disease - therapy ; Humans ; Medical sciences ; Obstetrics and Gynecology ; Oligohydramnios - prevention & control ; Pregnancy ; Pregnancy Complications, Hematologic - therapy ; Pregnancy Trimester, Third - blood ; Retrospective Studies ; Sickle cell disease ; Transfusion</subject><ispartof>International journal of gynecology and obstetrics, 2007-01, Vol.96 (1), p.8-11</ispartof><rights>International Federation of Gynecology and Obstetrics</rights><rights>2006 International Federation of Gynecology and Obstetrics</rights><rights>2007 International Federation of Gynecology and Obstetrics</rights><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4858-af8f9ff308e751dd0f6ec0342400581cb7113a80fcd36eb296876302d039a4663</citedby><cites>FETCH-LOGICAL-c4858-af8f9ff308e751dd0f6ec0342400581cb7113a80fcd36eb296876302d039a4663</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1016%2Fj.ijgo.2006.09.017$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1016%2Fj.ijgo.2006.09.017$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18466888$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17188271$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gilli, S.C</creatorcontrib><creatorcontrib>De Paula, E.V</creatorcontrib><creatorcontrib>Biscaro, F.P</creatorcontrib><creatorcontrib>Marques, J.F</creatorcontrib><creatorcontrib>Costa, F.F</creatorcontrib><creatorcontrib>Saad, S.T</creatorcontrib><title>Third-trimester erythrocytapheresis in pregnant patients with sickle cell disease</title><title>International journal of gynecology and obstetrics</title><addtitle>Int J Gynaecol Obstet</addtitle><description>Abstract Objective To evaluate the effects of prophylactic transfusion by means of erythrocytapheresis at the beginning of the third trimester of pregnancy in women with sickle cell disease (SCD). Methods A cohort of 14 pregnant women with SCD who received prophylactic erythrocytapheresis transfusions at the beginning of the third trimester was retrospectively compared with a cohort of 17 pregnant women who received simple prophylactic transfusions for no indication other than SCD severity. Results Prophylactic erythrocytapheresis transfusions were associated with a lower risk of intrauterine growth restriction (OR, 0.11; 95% confidence interval, 0.01–1.00) and oligohydramnios (OR, 0.65; 95% confidence interval, 0.45–0.92) in pregnant women with SCD. Conclusion These results suggest that erythrocytapheresis transfusions are beneficial in women with SCD who are in the third trimester of pregnancy. Given the decrease in transfusion risks, this therapy deserves further evaluation in future trials.</description><subject>Adult</subject><subject>Anemia, Sickle Cell - therapy</subject><subject>Anemias. Hemoglobinopathies</subject><subject>Biological and medical sciences</subject><subject>Blood Component Removal</subject><subject>Diseases of red blood cells</subject><subject>Erythrocytapheresis</subject><subject>Erythrocyte Transfusion</subject><subject>Female</subject><subject>Fetal Growth Retardation - prevention & control</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Hemoglobin SC Disease - therapy</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Obstetrics and Gynecology</subject><subject>Oligohydramnios - prevention & control</subject><subject>Pregnancy</subject><subject>Pregnancy Complications, Hematologic - therapy</subject><subject>Pregnancy Trimester, Third - blood</subject><subject>Retrospective Studies</subject><subject>Sickle cell disease</subject><subject>Transfusion</subject><issn>0020-7292</issn><issn>1879-3479</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkkGL1DAUx4Mo7rj6BTxIL3prfUnaNAURZNF1ZWER13PIJK876Xbamtdx6bc3ZQYWPIinXH7_l39-eYy95lBw4Op9V4TubiwEgCqgKYDXT9iG67rJZVk3T9kGQEBei0acsRdEHUBCOH_OztKhtaj5hn2_3YXo8zmGPdKMMcO4zLs4umW20w4jUqAsDNkU8W6ww5xNdg44zJQ9hHmXUXD3PWYO-z7zgdASvmTPWtsTvjqd5-znl8-3F1_z65vLq4tP17krdaVz2-q2aVsJGuuKew-tQgeyFCVApbnbpqbSamidlwq3olG6VhKEB9nYUil5zt4d505x_HVI5c0-0FrEDjgeyCjdyAoUJFAcQRdHooitmdJrbVwMB7OKNJ1ZRZpVpIHGJEsp9OY0_bDdo3-MnMwl4O0JsORs30Y7uECPnE4dtdaJq47cQ-hx-Y-rzdW3y5s19-GYw-Twd8BoyCXxDn2I6Gbjx_Dv_h__irs-DCE1vccFqRsPcUi_Y7ghYcD8WFdl3ZQkDMqq5PIPrLS3ZQ</recordid><startdate>200701</startdate><enddate>200701</enddate><creator>Gilli, S.C</creator><creator>De Paula, E.V</creator><creator>Biscaro, F.P</creator><creator>Marques, J.F</creator><creator>Costa, F.F</creator><creator>Saad, S.T</creator><general>Elsevier Ireland Ltd</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200701</creationdate><title>Third-trimester erythrocytapheresis in pregnant patients with sickle cell disease</title><author>Gilli, S.C ; De Paula, E.V ; Biscaro, F.P ; Marques, J.F ; Costa, F.F ; Saad, S.T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4858-af8f9ff308e751dd0f6ec0342400581cb7113a80fcd36eb296876302d039a4663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adult</topic><topic>Anemia, Sickle Cell - therapy</topic><topic>Anemias. Hemoglobinopathies</topic><topic>Biological and medical sciences</topic><topic>Blood Component Removal</topic><topic>Diseases of red blood cells</topic><topic>Erythrocytapheresis</topic><topic>Erythrocyte Transfusion</topic><topic>Female</topic><topic>Fetal Growth Retardation - prevention & control</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Hemoglobin SC Disease - therapy</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Obstetrics and Gynecology</topic><topic>Oligohydramnios - prevention & control</topic><topic>Pregnancy</topic><topic>Pregnancy Complications, Hematologic - therapy</topic><topic>Pregnancy Trimester, Third - blood</topic><topic>Retrospective Studies</topic><topic>Sickle cell disease</topic><topic>Transfusion</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gilli, S.C</creatorcontrib><creatorcontrib>De Paula, E.V</creatorcontrib><creatorcontrib>Biscaro, F.P</creatorcontrib><creatorcontrib>Marques, J.F</creatorcontrib><creatorcontrib>Costa, F.F</creatorcontrib><creatorcontrib>Saad, S.T</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of gynecology and obstetrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gilli, S.C</au><au>De Paula, E.V</au><au>Biscaro, F.P</au><au>Marques, J.F</au><au>Costa, F.F</au><au>Saad, S.T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Third-trimester erythrocytapheresis in pregnant patients with sickle cell disease</atitle><jtitle>International journal of gynecology and obstetrics</jtitle><addtitle>Int J Gynaecol Obstet</addtitle><date>2007-01</date><risdate>2007</risdate><volume>96</volume><issue>1</issue><spage>8</spage><epage>11</epage><pages>8-11</pages><issn>0020-7292</issn><eissn>1879-3479</eissn><coden>IJGOAL</coden><abstract>Abstract Objective To evaluate the effects of prophylactic transfusion by means of erythrocytapheresis at the beginning of the third trimester of pregnancy in women with sickle cell disease (SCD). Methods A cohort of 14 pregnant women with SCD who received prophylactic erythrocytapheresis transfusions at the beginning of the third trimester was retrospectively compared with a cohort of 17 pregnant women who received simple prophylactic transfusions for no indication other than SCD severity. Results Prophylactic erythrocytapheresis transfusions were associated with a lower risk of intrauterine growth restriction (OR, 0.11; 95% confidence interval, 0.01–1.00) and oligohydramnios (OR, 0.65; 95% confidence interval, 0.45–0.92) in pregnant women with SCD. Conclusion These results suggest that erythrocytapheresis transfusions are beneficial in women with SCD who are in the third trimester of pregnancy. Given the decrease in transfusion risks, this therapy deserves further evaluation in future trials.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>17188271</pmid><doi>10.1016/j.ijgo.2006.09.017</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0020-7292 |
| ispartof | International journal of gynecology and obstetrics, 2007-01, Vol.96 (1), p.8-11 |
| issn | 0020-7292 1879-3479 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68935060 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Adult Anemia, Sickle Cell - therapy Anemias. Hemoglobinopathies Biological and medical sciences Blood Component Removal Diseases of red blood cells Erythrocytapheresis Erythrocyte Transfusion Female Fetal Growth Retardation - prevention & control Gynecology. Andrology. Obstetrics Hematologic and hematopoietic diseases Hemoglobin SC Disease - therapy Humans Medical sciences Obstetrics and Gynecology Oligohydramnios - prevention & control Pregnancy Pregnancy Complications, Hematologic - therapy Pregnancy Trimester, Third - blood Retrospective Studies Sickle cell disease Transfusion |
| title | Third-trimester erythrocytapheresis in pregnant patients with sickle cell disease |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T18%3A31%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Third-trimester%20erythrocytapheresis%20in%20pregnant%20patients%20with%20sickle%20cell%20disease&rft.jtitle=International%20journal%20of%20gynecology%20and%20obstetrics&rft.au=Gilli,%20S.C&rft.date=2007-01&rft.volume=96&rft.issue=1&rft.spage=8&rft.epage=11&rft.pages=8-11&rft.issn=0020-7292&rft.eissn=1879-3479&rft.coden=IJGOAL&rft_id=info:doi/10.1016/j.ijgo.2006.09.017&rft_dat=%3Cproquest_cross%3E68935060%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68935060&rft_id=info:pmid/17188271&rft_els_id=S0020729206004541&rfr_iscdi=true |